Importantly, the first recognition of SGLT2 inhibition benefits beyond diabetes control was by the Empagliflozin Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG ...

From ESS News Researchers in Switzerland are developing a biodegradable battery made from mushrooms. At Empa, a 3D printer has combined two types of mushrooms to create a small living cell that ...

You can learn more about the standards we follow in producing accurate, unbiased content in our editorial policy. multpl. “S&P 500 PE Ratio.” ...

How can we help you? The ceremony welcomed 50 graduates, joined by families and friends to celebrate their academic achievements and friendships forged during their journey. At the event, an ...

According to Empa, researchers have produced a 3D printed, biodegradable fungal battery. The living battery could reportedly supply power to sensors for agriculture or research in remote regions. Once ...

Empagliflozin (EMPA) is a novel sodium-glucose cotransporter 2 inhibitor (SGLT2i) that produces protective cardiovascular-renal outcomes in patients with diabetes. However, the effects of EMPA on ...

J.B. Maverick is an active trader, commodity futures broker, and stock market analyst 17+ years of experience, in addition to 10+ years of experience as a finance writer and book editor. Suzanne ...